The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
A host of UK law firms are preparing to fight pharmaceutical giant Merck over its controversial painkiller Vioxx, following Friday’s (19 August) US ruling against the company.
Several firms, including Alexander Harris, Freethcartwright, Hugh James and Liverpool firm MSB Solicitors, are taking cases to the US on behalf of patients and families who have suffered cardiovascular diseases as a result of taking the drug.
Meanwhile a consortium of firms – Irwin Mitchell, Leigh Day & Co, and Liverpool’s Goodmans – are gearing up to bring a claim in England under the UK’s Consumer Protection Act.
A partner close to the claimant group said the firms’ view was that the Consumer Protection Act would be the “fastest and fairest route” for UK claimants.
But the firms taking cases to the US believe that the claimants have a strong argument for compensation, following the Texas ruling last week on behalf of widow Carol Ernst whose husband died of a heart problem after taking Vioxx. Merck is appealing the judgment.
In the UK, Lovells product liability head John Meltzer is acting for Merck. Irwin Mitchell, Leigh Day and Goodmans have instructed Cloisters Chambers’ Brian Langstaff QC and Doughty Street Chambers’ Robin Oppenheim.